Trial Profile
Patient compliance and therapy management in postmenopausal patients with hormone receptor-positive breast cancer receiving letrozole treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms EVALUATE TM study
- 17 Nov 2015 New trial record
- 01 Dec 2009 Recruitment completed according to results published in the Geburtshilfe und Frauenheilkunde.